These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10707152)

  • 1. Severe systemic toxicity caused by brimonidine drops in an infant with presumed juvenile xanthogranuloma.
    Walters G; Taylor RH
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():797-8. PubMed ID: 10707152
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Bowman RJ; Cope J; Nischal KK
    Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops.
    Aristodemou P; Baer R
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):57-8. PubMed ID: 18209648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic side effects of ophthalmic drops.
    Levy Y; Zadok D
    Clin Pediatr (Phila); 2004; 43(1):99-101. PubMed ID: 14968900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charles Bonnet syndrome and brimonidine: comments.
    Rahman I; Fernando B; Harrison M
    Br J Ophthalmol; 2004 May; 88(5):724. PubMed ID: 15090439
    [No Abstract]   [Full Text] [Related]  

  • 7. The teardrop sign: a rare dermatological reaction to brimonidine.
    Scruggs JT; Whiteside-Michel J; Brodsky MC
    Br J Ophthalmol; 2000 Jun; 84(6):671-2. PubMed ID: 10896417
    [No Abstract]   [Full Text] [Related]  

  • 8. Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops.
    Tomsak RL; Zaret CR; Weidenthal D
    Br J Ophthalmol; 2003 Jul; 87(7):917. PubMed ID: 12812898
    [No Abstract]   [Full Text] [Related]  

  • 9. Update in glaucoma: the new pharmacotherapies. Brimonidine versus apraclonidine.
    Crichton AC
    Can J Ophthalmol; 1998 Aug; 33(5):254-5; discussion 257-8. PubMed ID: 9740952
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric systemic poisoning resulting from brimonidine ophthalmic drops.
    Fernandez MA; Rojas MD
    Pediatr Emerg Care; 2009 Jan; 25(1):59. PubMed ID: 19148021
    [No Abstract]   [Full Text] [Related]  

  • 11. Brimonidine and pupillary diameter.
    Mastropasqua L; Carpineto P; Ciancaglini M
    Ophthalmology; 1998 Aug; 105(8):1352-3. PubMed ID: 9709738
    [No Abstract]   [Full Text] [Related]  

  • 12. Ophthalmic drops causing coma in an infant.
    Berlin RJ; Lee UT; Samples JR; Rich LF; Tang-Liu DD; Sing KA; Steiner RD
    J Pediatr; 2001 Mar; 138(3):441-3. PubMed ID: 11241061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy.
    Gordon RN; Liebmann JM; Greenfield DS; Lama P; Ritch R
    Eye (Lond); 1998; 12 ( Pt 4)():697-700. PubMed ID: 9850267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More than just an ocular solution.
    Pekdemir M; Yanturali S; Karakus G
    Emerg Med J; 2005 Oct; 22(10):753-4. PubMed ID: 16189050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis caused by topical eye drops.
    Spaeth GL
    Am J Ophthalmol; 2006 Oct; 142(4):706. PubMed ID: 17011880
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.
    Kesler A; Shemesh G; Rothkoff L; Lazar M
    J Cataract Refract Surg; 2004 Aug; 30(8):1707-10. PubMed ID: 15313294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma.
    Korsch E; Grote A; Seybold M; Soditt V
    Eur J Pediatr; 1999 Aug; 158(8):685. PubMed ID: 10445353
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs.
    Welch SL; Richardson JA
    Vet Hum Toxicol; 2002 Feb; 44(1):34-5. PubMed ID: 11824775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
    Osborne SA; Montgomery DM; Morris D; McKay IC
    Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.